Annotated Medicine and Device Lists


Ranitidine

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines Others observations:
The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this class of medicine at its next meeting.
This medicine has the best evidence for effectiveness and safety.
Peru 17.1.2 Anti-Ulcers No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Gi Ulcer Healing-H2 Receptor Antagonist No observations
Belize. National Drug Formulary 17.01 Antacids and other antiulcer medicines No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 01.03.01 H2-receptor antagonists No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations
Guyana. Essential Medicines List. 2020-2021 H₂ - Receptor Antagonists No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 56:40 Miscellaneous Gastrointestinal Agents No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.12 Histamine Receptor Antagonists No observations

This medicine is present in:

List Section Observation
Chile. Formulario Nacional de Medicamentos. 2005 16.01. ANTIACIDOS Y OTROS MEDICAMENTOS ANTIULCEROSOS No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 02 AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 02. AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations

This medicine is present in:

List Section Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
chlorhidrato INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS LÍQUIDAS DE ADMINISTRACIÓN ORAL
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 07.02. MEDICAMENTOS ANTIULCEROSOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines Others observations:
The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this class of medicine at its next meeting.
This medicine has the best evidence for effectiveness and safety.
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO Others observations:
USO EXCLUSIVO DE: PEDIATRÍA Y GASTROENTEROLOGÍA
Guyana. Essential Medicines List. 2020-2021 H₂ - Receptor Antagonists No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations
Bahamas. Drug Formulary 01. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM No observations

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Belize. National Drug Formulary 17.01 Antacids and other antiulcer medicines No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 01.03.01 H2-receptor antagonists No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations

This medicine is present in:

List Section Observation
Peru 17.1.2 Anti-Ulcers No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Gi Ulcer Healing-H2 Receptor Antagonist No observations
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
EST. X 3 BLISTER X 10 TABLETAS REVESTIDAS C/U.
Mexico. Cuadro Basico de Medicamentos - 2017 08. GASTROENTEROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 A. APARELHO DIGESTIVO E METABOLISMO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 02. AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 16.01. ANTIACIDOS Y OTROS MEDICAMENTOS ANTIULCEROSOS No observations
Guyana. Essential Medicines List. 2020-2021 H₂ - Receptor Antagonists No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 56:40 Miscellaneous Gastrointestinal Agents No observations
Suriname. NGK-C-011 17.1 Antacids and other anti-ulcer agents No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.12 Histamine Receptor Antagonists No observations
Bahamas. Drug Formulary 01. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 01.03.01 H2-receptor antagonists No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 17.1. Antiulcer medicines Others observations:
The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this class of medicine at its next meeting.
This medicine has the best evidence for effectiveness and safety.
Peru 17.1.2 Anti-Ulcers No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 06.04 ULCER HEALING DRUGS No observations
El Salvador - 2019 AGENTES PARA TRASTORNOS RELACIONADOS CON ÁCIDO No observations
Belize. National Drug Formulary 17.01 Antacids and other antiulcer medicines No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 02 AGENTES PARA EL TRATAMIENTO DE ALTERACIONES CAUSADAS POR ÁCIDOS No observations

This medicine is present in:

List Section Observation
Chile. Formulario Nacional de Medicamentos. 2005 16.01. ANTIACIDOS Y OTROS MEDICAMENTOS ANTIULCEROSOS No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 56:40 Miscellaneous Gastrointestinal Agents No observations
Haiti. National List of Essential Medicines 17.01 Anti-acid/ Anti-ulcer No observations
Barbados. Barbados National Drug Formulary (BNDF) 56.28.12 Histamine Receptor Antagonists No observations
Bahamas. Drug Formulary 01. DRUGS ACTING ON THE GASTROINTESTINAL SYSTEM No observations

Information Resources: Ranitidine